A syndrome of acute zinc loss. Cerebellar dysfunction, mental changes, anorexia, and taste and smell dysfunction.
Oral administration of the amino acid histidine to six patients with progressive systemic sclerosis produced anorexia, taste ans smell dysfunction, changes in mentation, and cerebellar dysfunction in each patient; these changes were associated with significant decreases in serum zinc concentration and significant increases in urinary zinc excretion. Administration of zinc ion, even with continued histidine administration, returned each of the signs and symptoms to or toward normal within 8 to 24 hours in each patient at the same time that correction of the serum zinc concentration occurred. The signs and symptoms noted constitute a syndrome related to acute zinc loss.
D000328:Adult; D000855:Anorexia / Q000139:chemically induced; D002526:Cerebellar Diseases / Q000139:chemically induced*; D002648:Child; D005260:Female; D006639:Histidine / Q000009:adverse effects*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced; D008659:Metabolic Diseases / Q000139:chemically induced*; D008875:Middle Aged; D000857:Olfaction Disorders / Q000139:chemically induced; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013577:Syndrome; D013651:Taste Disorders / Q000139:chemically induced; D015032:Zinc / Q000378:metabolism*
D006639:Histidine; D015032:Zinc